Vutrisiran

Vutrisiran
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T39304-25mg 25 mg

7 - 10 business days*

1,520.00€
 
Description: Vutrisiran (ALN-TTRsc02) is an investigational, liver-directed small interfering... more
Product information "Vutrisiran"
Description: Vutrisiran (ALN-TTRsc02) is an investigational, liver-directed small interfering ribonucleic acid (siRNA) compound designed for research on transthyretin (TTR)-mediated amyloidosis. Target: Others. References: Bahru A Habtemariam, et al. Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects. Clin Pharmacol Ther. 2021 Feb,109(2):372-382.
Keywords: ALN-TTRsc02
Supplier: TargetMol
Supplier-Nr: T39304

Properties

Application: Targets transthyretin (TTR)

Database Information

CAS : 1867157-35-4| Matching products
KEGG ID : K20731 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Vutrisiran"
Write a review
or to review a product.
Viewed